Publication date: Available online 27 October 2026 Source: JTO Clinical and Research Reports Author(s): Sakthi Kumar, Suresh S. Ramalingam, Ticiana Leal, Jennifer W. Carlisle
Brief report: Clinical use of zongertinib in patients with HER2 mutated NSCLC with brain metastases with or without leptomeningeal disease. // JTO Clinical and Research Reports. – URL: https://www.sciencedirect.com/science/article/pii/S2666364326001542?dgcid=rss_sd_all
Brief report: Clinical use of zongertinib in patients with HER2 mutated NSCLC with brain metastases with or without leptomeningeal disease. JTO Clinical and Research Reports. https://www.sciencedirect.com/science/article/pii/S2666364326001542?dgcid=rss_sd_all
“Brief report: Clinical use of zongertinib in patients with HER2 mutated NSCLC with brain metastases with or without leptomeningeal disease.” JTO Clinical and Research Reports.
@article{article90121,
title = {Brief report: Clinical use of zongertinib in patients with HER2 mutated NSCLC with brain metastases with or without leptomeningeal disease},
journal = {JTO Clinical and Research Reports},
url = {https://www.sciencedirect.com/science/article/pii/S2666364326001542?dgcid=rss_sd_all}
}